Page last updated: 2024-10-30

lansoprazole and Ischemia

lansoprazole has been researched along with Ischemia in 2 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Research Excerpts

ExcerptRelevanceReference
"Lansoprazole inhibits lipid peroxidation and reduces development of intestinal mucosal inflammation induced by I/R in rats, suggesting that lansoprazole may have a therapeutic potential for I/R injury."7.72Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. ( Ichikawa, H; Isozaki, Y; Katada, K; Naito, Y; Okanoue, T; Takagi, T; Tomatsuri, N; Uchiyama, K; Yoshida, N; Yoshikawa, T, 2004)
"Lansoprazole inhibits lipid peroxidation and reduces development of intestinal mucosal inflammation induced by I/R in rats, suggesting that lansoprazole may have a therapeutic potential for I/R injury."3.72Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. ( Ichikawa, H; Isozaki, Y; Katada, K; Naito, Y; Okanoue, T; Takagi, T; Tomatsuri, N; Uchiyama, K; Yoshida, N; Yoshikawa, T, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ichikawa, H1
Yoshida, N1
Takagi, T1
Tomatsuri, N1
Katada, K1
Isozaki, Y1
Uchiyama, K1
Naito, Y1
Okanoue, T1
Yoshikawa, T1
Schönhöfer, PS1

Other Studies

2 other studies available for lansoprazole and Ischemia

ArticleYear
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.
    World journal of gastroenterology, 2004, Oct-01, Volume: 10, Issue:19

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Gastrointestinal Agents; Inflammation; Intestinal

2004
Safety of omeprazole and lansoprazole.
    Lancet (London, England), 1994, May-28, Volume: 343, Issue:8909

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Humans; Ischemia; Lansoprazole; Male; Mi

1994